96 related articles for article (PubMed ID: 16620633)
21. [Antiherpetic effect of RNA-tilorone molecular complex in cell culture].
Skrots'ka OI; Zholobak NM; Antonenko SV; Spivak MIa; Karpov OV
Mikrobiol Z; 2007; 69(3):62-8. PubMed ID: 17682533
[TBL] [Abstract][Full Text] [Related]
22. Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection.
Casper C
Herpes; 2006 Aug; 13(2):42-7. PubMed ID: 16895654
[TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.
Naesens L; Bonnafous P; Agut H; De Clercq E
J Clin Virol; 2006 Dec; 37 Suppl 1():S69-75. PubMed ID: 17276373
[TBL] [Abstract][Full Text] [Related]
24. Main structural and stereochemical aspects of the antiherpetic activity of nonahydroxyterphenoyl-containing C-glycosidic ellagitannins.
Quideau S; Varadinova T; Karagiozova D; Jourdes M; Pardon P; Baudry C; Genova P; Diakov T; Petrova R
Chem Biodivers; 2004 Feb; 1(2):247-58. PubMed ID: 17191843
[TBL] [Abstract][Full Text] [Related]
25. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
Lockhart SM; Salvaggio MR; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2007 Oct; 100(10):388-95. PubMed ID: 18085096
[TBL] [Abstract][Full Text] [Related]
26. Structural biology: antiviral drugs fit for a purpose.
Luo M
Nature; 2006 Sep; 443(7107):37-8. PubMed ID: 16915238
[No Abstract] [Full Text] [Related]
27. The capsid protein of human immunodeficiency virus: molecular recognition and design of antiviral agents.
Neira JL
FEBS J; 2009 Nov; 276(21):6097. PubMed ID: 19825043
[No Abstract] [Full Text] [Related]
28. New antivirals and drug resistance.
Colman PM
Annu Rev Biochem; 2009; 78():95-118. PubMed ID: 19254207
[TBL] [Abstract][Full Text] [Related]
29. Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy.
Crum-Cianflone NF; Wallace MR; Looney D
AIDS; 2006 Jul; 20(11):1567-9. PubMed ID: 16847420
[No Abstract] [Full Text] [Related]
30. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.
Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC
Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855
[TBL] [Abstract][Full Text] [Related]
31. Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation.
Ghosh T; Chattopadhyay K; Marschall M; Karmakar P; Mandal P; Ray B
Glycobiology; 2009 Jan; 19(1):2-15. PubMed ID: 18815291
[TBL] [Abstract][Full Text] [Related]
32. A case for developing antiviral drugs against polio.
Collett MS; Neyts J; Modlin JF
Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
35. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
[TBL] [Abstract][Full Text] [Related]
36. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
37. FDA's meeting of Antiviral Drugs Advisory Committee.
AIDS Alert; 2006 Oct; 21(10):118-9. PubMed ID: 17063593
[No Abstract] [Full Text] [Related]
38. Anti-influenza drugs: the development of sialidase inhibitors.
von Itzstein M; Thomson R
Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
[TBL] [Abstract][Full Text] [Related]
39. Interactions of antiviral indolo[2,3-b]quinoxaline derivatives with DNA.
Wilhelmsson LM; Kingi N; Bergman J
J Med Chem; 2008 Dec; 51(24):7744-50. PubMed ID: 19053744
[TBL] [Abstract][Full Text] [Related]
40. Good science behind hepatitis C virus antiviral drug development: necessary but not sufficient.
Pappas SC
Hepatology; 2007 Nov; 46(5):1317-8. PubMed ID: 17969055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
